Literature DB >> 1715780

Proteolipid DM-20 predominates over PLP in peripheral nervous system.

D Pham-Dinh1, M C Birling, G Roussel, A Dautigny, J L Nussbaum.   

Abstract

The major central nervous system (CNS) myelin proteolipid (PLP) is also expressed in the peripheral nervous system (PNS). This paper gives evidence that DM-20, an isoform of PLP, also occurs in rat sciatic nerves, where, in contrast to what is seen in CNS myelin, it predominates over PLP. This conclusion was reached on the basis of results obtained by immunoblot analysis of a crude proteolipid extract from adult peripheral nerve with two site-specific anti-proteolipid (PLP and DM-20) antibodies. This finding was further corroborated by characterization of the products obtained by Polymerase Chain Reaction (PCR) amplification of cDNAs synthesized from total RNA of 14-day-old sciatic nerves. The significance of the occurrence of these proteolipids in PNS remains obscure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715780     DOI: 10.1097/00001756-199102000-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.

Authors:  Anders A F Sima; Christopher R Pierson; Randall L Woltjer; Grace M Hobson; Jeffrey A Golden; William J Kupsky; Galen M Schauer; Thomas D Bird; Robert P Skoff; James Y Garbern
Journal:  Acta Neuropathol       Date:  2009-06-27       Impact factor: 17.088

2.  Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord.

Authors:  Christelle Girard; Alexis-Pierre Bemelmans; Noëlle Dufour; Jacques Mallet; Corinne Bachelin; Brahim Nait-Oumesmar; Anne Baron-Van Evercooren; François Lachapelle
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

3.  Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid.

Authors:  D Pham-Dinh; J L Popot; O Boespflug-Tanguy; P Landrieu; J F Deleuze; J Boué; P Jollès; A Dautigny
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.

Authors:  Michael E Shy; Grace Hobson; Manisha Jain; Odile Boespflug-Tanguy; James Garbern; Karen Sperle; Wen Li; Alex Gow; Diana Rodriguez; Enrico Bertini; Pedro Mancias; Karen Krajewski; Richard Lewis; John Kamholz
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

5.  Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. PMD Clinical Group.

Authors:  O Boespflug-Tanguy; C Mimault; J Melki; A Cavagna; G Giraud; D Pham Dinh; B Dastugue; A Dautigny
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

6.  Proteolipid/DM-20 proteins bearing the paralytic tremor mutation in peripheral nerves and transfected Cos-7 cells.

Authors:  M Tosic; A Gow; M Dolivo; K Domanska-Janik; R A Lazzarini; J M Matthieu
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

Review 7.  Neurogenetics of Pelizaeus-Merzbacher disease.

Authors:  M Joana Osório; Steven A Goldman
Journal:  Handb Clin Neurol       Date:  2018

8.  PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations.

Authors:  Nancy C Cloake; Jun Yan; Atefeh Aminian; Michael P Pender; Judith M Greer
Journal:  J Clin Med       Date:  2018-10-11       Impact factor: 4.241

9.  Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1.

Authors:  Takeshi Kouga; Shiro Koizume; Shiho Aoki; Eriko Jimbo; Takanori Yamagata; Ken Inoue; Hitoshi Osaka
Journal:  Mol Genet Metab Rep       Date:  2019-05-07

10.  A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice.

Authors:  P A Wight; C S Duchala; C Readhead; W B Macklin
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.